BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou Z, Jiang N, Chen J, Zheng C, Guo Y, Ye R, Qi R, Shen J. Selectively down-regulated PD-L1 by albumin-phenformin nanoparticles mediated mitochondrial dysfunction to stimulate tumor-specific immunological response for enhanced mild-temperature photothermal efficacy. J Nanobiotechnology 2021;19:375. [PMID: 34794446 DOI: 10.1186/s12951-021-01124-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Shen Y, Zou Y, Bie B, Dong C, Lv Y. Combining dual-targeted liquid metal nanoparticles with autophagy activation and mild photothermal therapy to treat metastatic breast cancer and inhibit bone destruction. Acta Biomater 2023;157:578-92. [PMID: 36442822 DOI: 10.1016/j.actbio.2022.11.044] [Reference Citation Analysis]
2 Consoli GML, Forte G, Maugeri L, Consoli V, Sorrenti V, Vanella L, Buscarino G, Agnello S, Camarda M, Granata G, Ferreri L, Petralia S. Near-Infrared-Responsive Choline-Calix[4]arene-Gold Nanostructures for Potential Photothermal Cancer Treatment. ACS Appl Nano Mater 2022. [DOI: 10.1021/acsanm.2c04501] [Reference Citation Analysis]
3 Li J, Lu W, Yang Y, Xiang R, Ling Y, Yu C, Zhou Y. Hybrid Nanomaterials for Cancer Immunotherapy. Adv Sci (Weinh) 2022;:e2204932. [PMID: 36567305 DOI: 10.1002/advs.202204932] [Reference Citation Analysis]
4 Zhou Z, Liu Y, Song W, Jiang X, Deng Z, Xiong W, Shen J. Metabolic reprogramming mediated PD-L1 depression and hypoxia reversion to reactivate tumor therapy. J Control Release 2022;352:793-812. [PMID: 36343761 DOI: 10.1016/j.jconrel.2022.11.004] [Reference Citation Analysis]
5 Zheng C, Luo W, Liu Y, Chen J, Deng H, Zhou Z, Shen J. Killing Three Birds with One Stone: Multi-stage Metabolic Regulation Mediated by Clinically Usable Berberine Liposome to Overcome Photodynamic Immunotherapy Resistance. Chemical Engineering Journal 2022. [DOI: 10.1016/j.cej.2022.140164] [Reference Citation Analysis]
6 Zhou Z, Zheng C, Liu Y, Luo W, Deng H, Shen J. Chitosan biguanide induced mitochondrial inhibition to amplify the efficacy of oxygen-sensitive tumor therapies. Carbohydrate Polymers 2022;295:119878. [DOI: 10.1016/j.carbpol.2022.119878] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Zhou Z, Liu Y, Jiang X, Zheng C, Luo W, Xiang X, Qi X, Shen J. Metformin modified chitosan as a multi-functional adjuvant to enhance cisplatin-based tumor chemotherapy efficacy. International Journal of Biological Macromolecules 2022. [DOI: 10.1016/j.ijbiomac.2022.10.167] [Reference Citation Analysis]
8 Zhou Z, Chen J, Liu Y, Zheng C, Luo W, Chen L, Zhou S, Li Z, Shen J. Cascade two-stage tumor re-oxygenation and immune re-sensitization mediated by self-assembled albumin-sorafenib nanoparticles for enhanced photodynamic immunotherapy. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.07.023] [Reference Citation Analysis]
9 Kuzmanovszki D, Kiss N, Tóth B, Kerner T, Tóth V, Szakonyi J, Lőrincz K, Hársing J, Imrédi E, Pfund A, Szabó Á, Brodszky V, Rencz F, Holló P. Anti-PD-1 Monotherapy in Advanced Melanoma—Real-World Data from a 77-Month-Long Retrospective Observational Study. Biomedicines 2022;10:1737. [DOI: 10.3390/biomedicines10071737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li C, Li T, Niu K, Xiao Z, Huang J, Pan X, Sun Y, Wang Y, Ma D, Xie P, Shuai X, Meng X. Mild phototherapy mediated by manganese dioxide-loaded mesoporous polydopamine enhances immunotherapy against colorectal cancer. Biomater Sci 2022. [PMID: 35670464 DOI: 10.1039/d2bm00505k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhou L, Feng B, Wang H, Wang D, Li Y. A bispecific nanomodulator to potentiate photothermal cancer immunotherapy. Nano Today 2022;44:101466. [DOI: 10.1016/j.nantod.2022.101466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]